ADMA Biologics (ADMA) Competitor Comparison
We are evaluating the key criteria listed to compare ADMA Biologics (ADMA) against its competitors in the Biotechnology industry.
Market Capitalization
112 / 368Gross Profits
70 / 278Total Revenue
50 / 300EBITDA
28 / 337Free Cashflow
126 / 352Quick Ratio
271 / 357Earnings per Share
36 / 359Dividend yield
0 / 6Total Cash
238 / 358Performance 3 years
1 / 368Performance 5 years
23 / 368Performance 10 years
70 / 368Linearity 3 years
361 / 368Linearity 5 years
354 / 368Linearity 10 years
320 / 367Total Rank
222 / 368Dividend Rank
333 / 368Valuation Rank
136 / 368Piotroski Rank
60 / 368Muliplier Rank
254 / 368Market Capitalization - ADMA ranking 112 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.